跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NEO HEALTH APPLE BLACKCURRANT EFFERVESCENT ELECTROLYTE TABLETS - TGA Drug Approval Details
Approvals
/
TGA
/
NEO HEALTH APPLE BLACKCURRANT EFFERVESCENT ELECTROLYTE TABLETS
Approved
STANDARD
NEO HEALTH APPLE BLACKCURRANT EFFERVESCENT ELECTROLYTE TABLETS
Neo Health (OTC) Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
ce6fcd4a2fe4b13f
Company
Neo Health (OTC) Pty Ltd
Type
Standard
Approval Details
Approval Id
ce6fcd4a2fe4b13f
Product Name
NEO HEALTH APPLE BLACKCURRANT EFFERVESCENT ELECTROLYTE TABLETS
Artg Id
285020
Artg Name
NEO HEALTH APPLE BLACKCURRANT EFFERVESCENT ELECTROLYTE TABLETS
Sponsor
Neo Health (OTC) Pty Ltd
Company Detail Path
/organization/neo-health-otc-pty-ltd
Artg Date
2017-01-27
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LI
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
ce6fcd4a2fe4b13f
Type
Standard
Back to TGA Approvals
